Clinical trials: Cardiogenic Shock

Shock, Cardiogenic, High Risk Percutaneous Coronary Interventions

Synchronized Cardiac Assist for Cardiogenic Shock

• Completed
• Age: 18 to 85 years
• Observational study
• Medical device
• Results posted

The purpose of this study is to collect prospective safety and performance information for the i-COR® device using synchronized cardiac assist in the setting of combined heart-lung failure or in high risk percutaneous…

Trial name

NCT02697006

Testing

i-cor Synchronized Cardiac Assist Device

Where

Germany

Volunteers

47 people

Sponsor

Xenios AG